Scinai Immunotherapeutics Ltd (SCNI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.05M
Last updated: Nov 17, 2026 at 10:54 AM ET
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 63.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 25.2, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SCNI
News
SCNI Valuation
- P/FCF
- -0.0x
- P/B
- 0.0x
SCNI Profitability: Margins, ROIC and FCF
Scinai Immunotherapeutics (SCNI) has a gross margin of -142.2%, an operating margin of -276.1% and a net margin of -80.1%. It posts a -253.3% FCF margin.
- Gross margin
- -142.2%
- Operating margin
- -276.1%
- Net margin
- -80.1%
- ROE
- -26.1%
- FCF margin
- -253.3%
- FCF yield
- -8095.8%
Scinai Immunotherapeutics Competitors
The companies most similar to Scinai Immunotherapeutics (SCNI) include Scisparc, HCW Biologics and Silexion Therapeutics.
Sector: Healthcare
Companies most similar to Scinai ImmunotherapeuticsSCNI Bull Case vs Bear Case
Bull case
- SCNI grew quarterly revenue 572.0% year over year.
Bear case
- SCNI has a -80.1% net profit margin.
- SCNI beat EPS estimates in 37.5% of its last 8 reported quarters.
SCNI Earnings: Beat Rate
Scinai Immunotherapeutics (SCNI) beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate (37.5%).
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -57.1%
SCNI Earnings Call
The latest SCNI earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptUpdated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SCNI
Does SCNI pay dividends?
Scinai Immunotherapeutics Ltd (SCNI) does not currently pay a regular dividend.
What is SCNI's market cap?
Scinai Immunotherapeutics Ltd (SCNI) has a market capitalization of $1.05M with a current stock price of $0.40.
SCNI pages: Overview, Earnings, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.